Drug Profile
Recombinant factor VIIa - SmartZyme BioPharma
Alternative Names: rFVIIa - SmartZyme BioPharma; SZ 7Latest Information Update: 28 Aug 2021
Price :
$50
*
At a glance
- Originator SmartZyme Biopharma
- Class Blood coagulation factors; Coagulants; Recombinant proteins; Serine endopeptidases
- Mechanism of Action Blood coagulation factor replacements; Factor VII replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Haemorrhage
Most Recent Events
- 28 Aug 2021 No recent reports of development identified for research development in Haemorrhage in Israel (Parenteral, Controlled release)
- 05 Jul 2017 Early research in Haemorrhage in Israel (SmartZyme BioPharma pipeline, July 2017)